Algonomics announced on July 9 that its anticancer gene therapy platform, "RZ-002," has received a patent registration decision in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results